glp 1 heart failure GLP-1 Receptor Agonists in JCI - Cardioprotective GLP-1 metabolite

PERIOPERATIVE CONSIDERATIONS FOR GLP-1RAS AND GIP/GLP-1RA THERAPY Increased residual gastric content There is emerging evidence that the use of GLP-1 receptor agonists is associated with increased RGC, based on studies in patients undergoing endoscopy, despite fasting for at least 8 hours [68]

Incorporating omega 3 supplements during GLP-1 treatment can also support cognitive functions and help mitigate the natural inflammation that accompanies metabolic adjustments

A systematic review and meta-analysis of 55 RCTs (106,395 participants) published in Gastroenterology in 2025 confirmed elevated risk of cholelithiasis, cholecystitis, and gastrointestinal events across the class

You want to make sure this is the best environment possible